Cargando…

Association between serum complements and kidney function in patients with diabetic kidney disease

OBJECTIVE: We aimed to explore the association between serum complements and kidney function of diabetic kidney disease (DKD) in Chinese patients. METHODS: This is a retrospective study involving 2,441 participants. DKD was diagnosed according to the Kidney Disease: Improving Global Outcomes (KDIGO)...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Meng-chao, Li, Jia-lin, Wang, Yue-fen, Meng, Yuan, Zheng, Gui-min, Cai, Zhen, Shen, Cun, Wang, Meng-di, Zhu, Xiang-gang, Chen, Yang-zi, Wang, Yu-lin, Zhao, Wen-jing, Niu, Wen-quan, Wang, Yao-xian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Endocrinology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10690951/ https://www.ncbi.nlm.nih.gov/pubmed/38047115 http://dx.doi.org/10.3389/fendo.2023.1195966

Ejemplares similares

Association between thyroid hormones and diabetic kidney disease in Chinese adults
por: Liu, Meng-chao, et al.
Publicado: (2023)

High Expression of Complement Components in the Kidneys of Type 2 Diabetic Rats With Diabetic Nephropathy
por: Huang, Yinqiong, et al.
Publicado: (2019)

Progress of new-onset diabetes after liver and kidney transplantation
por: Zhang, Zhen, et al.
Publicado: (2023)

Global, Regional, and National Burden of Diabetes-Related Chronic Kidney Disease From 1990 to 2019
por: Deng, Yujiao, et al.
Publicado: (2021)

Association between anemia-related biomarkers and the adequacy of peritoneal dialysis in Chinese patients with chronic kidney disease
por: Li, Jia-Lin, et al.
Publicado: (2023)

Diagnostic value of serum cathepsin S in type 2 diabetic kidney disease
por: Ren, Xuejing, et al.
Publicado: (2023)

Lifestyle factors, serum parameters, metabolic comorbidities, and the risk of kidney stones: a Mendelian randomization study
por: Liu, Minghui, et al.
Publicado: (2023)

5-Hydroxymethylcytosine profiles in plasma cell-free DNA reflect molecular characteristics of diabetic kidney disease
por: Chu, Jin-Lin, et al.
Publicado: (2022)

Association between metabolic scores for visceral fat and chronic kidney disease: A cross-sectional study
por: Yu, Peng, et al.
Publicado: (2022)

Association of serum 25-hydroxyvitamin D concentrations with all-cause mortality among individuals with kidney stone disease: the NHANES database prospective cohort study
por: Gao, Meng, et al.
Publicado: (2023)

Serum Cystatin C Trajectory Is a Marker Associated With Diabetic Kidney Disease
por: Wang, Nana, et al.
Publicado: (2022)

Exploration of Noninvasive Detection of Advanced Glycation End Products in the Lens to Screen for Diabetic Kidney Disease
por: Zhang, Xue-Meng, et al.
Publicado: (2022)

mDIXON-Quant for differentiation of renal damage degree in patients with chronic kidney disease
por: Wang, Yue, et al.
Publicado: (2023)

Corrigendum: mDIXON-Quant for differentiation of renal damage degree in patients with chronic kidney disease
por: Wang, Yue, et al.
Publicado: (2023)

REG1A and RUNX3 Are Potential Biomarkers for Predicting the Risk of Diabetic Kidney Disease
por: Wang, Xinyu, et al.
Publicado: (2022)

Contribution of mitochondrial gene variants in diabetes and diabetic kidney disease
por: Li, Meng, et al.
Publicado: (2022)

The Emerging Role of Bone-Derived Hormones in Diabetes Mellitus and Diabetic Kidney Disease
por: Li, Yixuan, et al.
Publicado: (2022)

Primary cilium in kidney development, function and disease
por: Bai, Yunfeng, et al.
Publicado: (2022)

Low Serum Dehydroepiandrosterone Is Associated With Diabetic Kidney Disease in Men With Type 2 Diabetes Mellitus
por: Zhang, Xinxin, et al.
Publicado: (2022)

The association of apolipoprotein B with chronic kidney disease in the Chinese population
por: Xu, Yu, et al.
Publicado: (2023)

Correlation Between Serum 25-Hydroxyvitamin D Levels in Albuminuria Progression of Diabetic Kidney Disease and Underlying Mechanisms By Bioinformatics Analysis
por: Huang, Bin, et al.
Publicado: (2022)

Evaluating the effectiveness and safety of acupuncture on serum uric acid in asymptomatic hyperuricemia population: a randomized controlled clinical trial study protocol
por: Yu, Ling-ling, et al.
Publicado: (2023)

Predicting diabetic kidney disease for type 2 diabetes mellitus by machine learning in the real world: a multicenter retrospective study
por: Liu, Xiao zhu, et al.
Publicado: (2023)

TLR4/NF-κB Signaling Induces GSDMD-Related Pyroptosis in Tubular Cells in Diabetic Kidney Disease
por: Wang, Youliang, et al.
Publicado: (2019)

Identification of Novel Key Molecular Signatures in the Pathogenesis of Experimental Diabetic Kidney Disease
por: Diao, Meng, et al.
Publicado: (2022)

Relationship Between Serum Testosterone Levels and Kidney Stones Prevalence in Men
por: Huang, Fang, et al.
Publicado: (2022)

Correlation analysis of serum IGF-1 and IL-6 and urinary albumin/creatinine ratio in patients with type 2 diabetic kidney disease
por: Liu, Guan-Wen, et al.
Publicado: (2022)

Association between triglyceride-glucose index and risk of end-stage renal disease in patients with type 2 diabetes mellitus and chronic kidney disease
por: Gao, Yue-Ming, et al.
Publicado: (2023)

The gut microbial metabolite trimethylamine N-oxide and cardiovascular diseases
por: Zhen, Jing, et al.
Publicado: (2023)

Cardiovascular outcomes and safety of SGLT2 inhibitors in chronic kidney disease patients
por: Chen, Xiutian, et al.
Publicado: (2023)

Metabolic reprogramming: A novel therapeutic target in diabetic kidney disease
por: Wang, Mengdi, et al.
Publicado: (2022)

Sacubitril/Valsartan contributes to improving the diabetic kidney disease and regulating the gut microbiota in mice
por: Wang, Peipei, et al.
Publicado: (2022)

Metabolic phenotypes and risk of end-stage kidney disease in patients with type 2 diabetes
por: Zhao, Lijun, et al.
Publicado: (2023)

Epigenetic modification in diabetic kidney disease
por: Liu, Zhe, et al.
Publicado: (2023)

Renal primary cilia lengthen in the progression of diabetic kidney disease
por: Bai, Yunfeng, et al.
Publicado: (2022)

Time-restricted feeding’s effect on overweight and obese patients with chronic kidney disease stages 3-4: A prospective non-randomized control pilot study
por: Lao, Bei-ni, et al.
Publicado: (2023)

Complement C1q as a Potential Biomarker for Obesity and Metabolic Syndrome in Chinese Adolescents
por: Yang, Xuelian, et al.
Publicado: (2020)

Research progress on extracellular vesicles in the renal tubular injury of diabetic kidney disease
por: Li, Shengjie, et al.
Publicado: (2023)

Highly pathogenic coronaviruses and the kidney
por: Wang, Fang, et al.
Publicado: (2022)

Mutational Profile and Potential Molecular Therapeutic Targets of Pheochromocytoma
por: Ma, Xiaosen, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_65bkdlspnirhnpl84i3manigl7